North Star Investment Management Corp. Brooklyn Immuno Therapeutics, Inc. Transaction History

North Star Investment Management Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$4.17 - $9.79 $1,251 - $2,936	-300 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$3.75 - $78.5 $34,473 - $721,650	-9,193 Reduced 96.84%	300 $5,000
Q1 2021 Apr 19, 2021	BUY	$3.72 - $12.76 $35,313 - $121,130	9,493 New	9,493 $35,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.